Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion-Reference-Cited by-同舟云学术

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion

Published:2019-05-06 Issue:7 Volume:33 Page:1224-1231
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Thyssen J.P.¹²,Bruin‐Weller M.S.³,Paller A.S.⁴,Leshem Y.A.⁵⁶,Vestergaard C.⁷,Deleuran M.⁸,Drucker A.M.⁹¹⁰,Foelster‐Holst R.¹¹,Traidl‐Hoffmann C.¹²¹³¹⁴,Eyerich K.¹⁵,Taieb A.¹⁶,Su J.C.¹⁷¹⁸,Bieber T.¹⁵¹⁹,Cork M.J.²⁰,Eichenfield L.F.²¹²²,Guttman‐Yassky E.²³,Wollenberg A.²⁴²⁵

Affiliation:

1. Department of Dermatology and Allergy Herlev and Gentofte Hospital Hellerup Denmark

2. Copenhagen Research Group for Inflammatory Skin (CORGIS) Herlev and Gentofte Hospital University of Copenhagen Hellerup Denmark

3. National Expertise Center of Atopic Dermatitis Department of Dermatology and Allergology University Medical Center Utrecht Utrecht The Netherlands

4. Departments of Dermatology and Pediatrics Northwestern University Feinberg School of Medicine Chicago IL USA

5. Department of Dermatology Beilinson Hospital Petah Tikva Israel

6. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

7. Department of Dermatology Aalborg University Hospital Aalborg Denmark

8. Department of Dermatology Aarhus University Hospital Aarhus Denmark

9. Division of Dermatology Department of Medicine University of Toronto Toronto ON Canada

10. Department of Medicine Women's College Research Institute Women's College Hospital Toronto ON Canada

11. Department of Dermatology, Venereology and Allergy University Clinics of Schleswig‐Holstein Kiel Germany

12. Institute of Environmental Medicine UNIKA‐T Technical University of Munich Augsburg Germany

13. Research Center for Environmental Health Helmholtz Zentrum München Augsburg Germany

14. Christine Kühne‐Center for Allergy Research and Education (CK‐CARE) Davos Switzerland

15. Department of Dermatology and Allergy Technical University of Munich Munich Germany

16. Department of Adult and Pediatric Dermatology CHU Bordeaux University of Bordeaux Bordeaux France

17. Department of Dermatology Eastern Health Monash University Parkville Vic Australia

18. Department of Pediatrics MCRI University of Melbourne Parkville Vic Australia

19. Department of Dermatology and Allergy University of Bonn Bonn Germany

20. Sheffield Dermatology Research Department of Infection, Immunity and Cardiovascular Disease The University of Sheffield Sheffield UK

21. Department of Dermatology San Diego School of Medicine University of California San Diego CA USA

22. Department of Pediatrics San Diego School of Medicine University of California San Diego CA USA

23. Icahn School of Medicine at Mount Sinai New York NY USA

24. Department of Dermatology and Allergy Ludwig‐Maximilian University Munich Germany

25. Klinikum Thalkirchner Straße München Germany

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.15608

Reference29 articles.

1. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients

2. Atopic keratoconjunctivitis: A review

3. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

4. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

5. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis;Dermatitis®;2024-02-01

2. A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults;Expert Review of Clinical Immunology;2023-11-13

3. Dupilumab induced ocular surface disease: A prospective case series;European Journal of Ophthalmology;2023-08-30

4. Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review;Journal of the American Academy of Dermatology;2023-08

5. Tralokinumab therapy for moderate‐to‐severe atopic dermatitis: Clinical outcomes with targeted IL‐13 inhibition;Allergy;2023-07-16